Olafur S. Palsson, Psy.D

e-mail: palsson2000@yahoo.com

Last updated July 28, 2015

Biosketch

Dr. Olafur S. Palsson is a licensed clinical psychologist. He is Professor of Medicine in the Division of Gastroenterology and Hepatology in the School of Medicine at the University of North Carolina at Chapel Hill. He is also Associate Editor of the journal Applied Psychophysiology and Biofeedback and advisory editor of the American Journal of Clinical Hypnosis. He was previously Assistant Professor of Psychiatry and Family Medicine at Eastern Virginia Medical School and served as Director of the EVMS Behavioral Medicine Clinic from 1996-2000. Dr. Palsson is originally from Iceland. After completing his doctoral degree in clinical psychology from the Virginia Consortium Program in Clinical Psychology, he completed a two-year post-doctoral fellowship in behavioral medicine in the Department of Medicine at the University of North Carolina at Chapel Hill, under the direction of Dr. William Whitehead. Dr. Palsson has conducted numerous research studies on the mind-body connection, including studies on hypnosis, biofeedback, psychological factors which influence health, and psychosocial influences on autonomic nervous system functioning, brainwave activity, hormones, and the immune system. Dr. Palsson has also worked for many years with scientists at NASA on innovative technologies to enhance human health and well-being through technologies that interface human psychology and physiology with computers. Dr. Palsson's work in behavioral medicine has been featured on television networks and in newspapers nationwide in the U.S., as well as in interviews by Newsweek, Prevention Magazine, American Health magazine, Natural Health Magazine, Health magazine, and Digestive Health and Nutrition. His work with NASA on health-enhancing technologies has been featured in articles in many science and technology oriented publications, including the magazines Science, Discover, and Wired, as well on BBC television and online news and the major U.S. television networks.

Journal articles, book chapters and scientific abstracts by Dr. Palsson (published and in press)

Book chapters:

Van Tilburg M.A.L., Weinland S.R., Palsson O.S. (2011). Brief Review of Mind-Body Medicine in Gastroenterology Practice. In: G Mullin (Ed). Integrative Gastroenterology, pp 326-336. New York, NY: Oxford University Press.

Palsson, O.S. & Blanco, H.E. (2009). Hipnoterapia en trastornos functionales gastrointestinales. In: Blanco HE, Rodriguez, JT & Schneider, RE (Eds). 753-763. Síndrome de Intestino Irritable y otros Trastornos Relacionados. Editorial Medica Panamerica: Mexico City.

Whitehead W.E. & Palsson O.S. (2007). Hyperalgesia in irritable bowel syndrome: cognitive and physiological influences on pain perception. In: Howden, C.W. Advances in Digestive Disease: AGA Institute Press, Bethesda, MD, pp. 37-48.

Palsson, O.S. & Moss, D. (2007). Irritable Bowel Syndrome (IBS) Concurrent with Fibromyalgia (Chapter 9). In S. Ostalecky (Ed.) Fibromyalgia: The complete guide from medical experts and patients. Jones & Bartlett; Sudbury, Massachusetts. 119-127.

Whitehead, W.E., Thompson, W.G., Palsson, O.S., Thiwan, S., Talley, N., Chey, W., Irvine, E.J., Drossman, D.A., & Walker, L. (2006). Development and validation of the Rome III Diagnostic Questionnaire (Chapter 16). In: Drossman DA, Corazziari, Delvaux M, Spiller R, Talley NJ, Thompson WG, and Whitehead WE (Eds), Rome III: The Functional Gastrointestinal Disorders. Degnon Associates, McLean, Virginia. 835-853.

Pope, A.T. and Palsson, O. (2003). Converging Technologies for Physiological Self-regulation. In Roco, M.C. and Bainbridge, W.S. (eds.) Converging Technologies for Improving Human Performance: Nanotechnology, Biotechnology, Information Technology and Cognitive Science. Dordrecht, The Netherlands: Kluwer Academic Publishers, 260- 270.

Palsson, O.S. & Collins, R. (2002). Functional bowel and anorectal disorders. In Moss, D., Wickramasekera, I.E., Davies, T.C., McGrady A. (eds.) Handbook of Mind-Body Medicine for Primary Care, pp. 299-311.Thousand Oaks, CA: Plenum.

Palsson, O.S. (2002). Urinary incontinence. In Moss, D., Wickramasekera, I.E., Davies, T.C., McGrady A. (eds.) Handbook of Mind-Body Medicine for Primary Care, pp. 312-321. Thousand Oaks, CA: Plenum.

Davies, S. M. & Palsson, O.S. (2002). Medical education for mind-body medicine. Handbook of Mind-Body Medicine for Primary Care, 443-448. Thousand Oaks, CA: Plenum.

Journal articles and published abstracts:

Palsson OS, van Tilburg M. Hypnosis and Guided Imagery Treatment for Gastrointestinal Disorders: Experience With Scripted Protocols Developed at the University of North Carolina. Am J Clin Hypn. 2015;58(1):5-21. doi: 10.1080/00029157.2015.1012705. PubMed PMID: 26046714.

Kiken LG, Garland EL, Bluth K, Palsson OS, Gaylord SA. From a state to a trait: Trajectories of state mindfulness in meditation during intervention predict changes in trait mindfulness. Pers Individ Dif. 2015 Jul 1;81:41-46. PubMed PMID: 25914434; PubMed Central PMCID: PMC4404745.

Riehl ME, Pandolfino JE, Palsson OS, Keefer L. Feasibility and acceptability of esophageal-directed hypnotherapy for functional heartburn. Dis Esophagus. 2015 Mar 30. doi: 10.1111/dote.12353. [Epub ahead of print] PubMed PMID: 25824436.

Ramsden CE, Faurot KR, Zamora D, Palsson OS, MacIntosh BA, Gaylord S, Taha AY, Rapoport SI, Hibbeln JR, Davis JM, Mann JD. Targeted alterations in dietary n-3 and n-6 fatty acids improve life functioning and reduce psychological distress among patients with chronic headache: a secondary analysis of a randomized trial. Pain. 2015 Apr;156(4):587-96. doi: 10.1097/01.j.pain.0000460348.84965.47. PubMed PMID: 25790451.

Palsson OS, Heymen S, Whitehead WE. Fecal Incontinence Is Associated With Clinically Significant Psychological Distress. Gastroenterology 2015, Vol. 148, Issue 4, S-305

Heymen S, Palsson OS, Whitehead WE. What Makes Discussing Fecal Incontinence (FI) With Providers Difficult? Gastroenterology 2015, Vol. 148, Issue 4, S-298 Palsson OS, Heymen S, Whitehead WE. Non-Gastrointestinal Pain Is Increased in Irritable Bowel Syndrome (IBS) but Does Not Account for Abdominal Pain. Gastroenterology 2015, Vol. 148, Issue 4, S-780

Pasricha S, Heymen S, Palsson OS, Whitehead WE. Men Report More Severe Fecal Incontinence Symptoms Than Women: Patients' Perspective. Gastroenterology 2015, Vol. 148, Issue 4, S-302–S-303

Riehl ME, Pandolfino JE, Palsson OS, Keefer L. The Feasibility and Acceptability of Esophageal-Directed Hypnotherapy for Functional Heartburn. Gastroenterology 2015, Vol. 148, Issue 4, S-618–S-619.

Smith SB, Maixner W, Palsson OS, van Tilburg MA, Kanazawa M, Whitehead WE. FKBP5 Gene Is Associated With IBS Diagnosis. Gastroenterology 2015, Vol. 146, Issue 5, S-109

Heymen S, Palsson OS, Kim SM, Twist S, Whitehead WE. Patient Preference for What Should Be Included in the Definition of Fecal Incontinence. Gastroenterology 2015, Vol. 146, Issue 5, S-720–S-721

Heymen S, Palsson OS, Kim SM, Twist S, Whitehead WE. Patient Preference for Defining Success in Fecal Incontinence Treatment Trials. Gastroenterology 2015, Vol. 146, Issue 5, S-721.

Ringel Y, Palsson OS, Ringel-Kulka T, Whitehead WE. Visceral Hypersensitivity Is an Important Etiological Factor in the Presence and Severity of Abdominal Bloating Symptoms in Patients With Irritable Bowel Syndrome (IBS). Gastroenterology 2015, Vol. 148, Issue 4, S-194.

van Tilburg MA, Palsson OS, Kanazawa M, Barrow DA, Whitehead WE. Cytokine Activation Is Associated With Psychological Distress, Motility and Visceral Hypersensitivity in Irritable Bowel Syndrome (IBS). Gastroenterology 2015, Vol. 148, Issue 4, S-38

Kanazawa M, Palsson OS, van Tilburg MA, Gangarosa LM, Fukudo S, Whitehead WE. Decreased Concentration of Whole Blood Serotonin in IBS With Diarrhea. Gastroenterology 2015, Vol. 148, Issue 4, S-779.

Heymen S, Palsson OS, Pasricha S, Whitehead WE. Fecal Incontinence Severity Index Helps to Identify Patients Who View Their Symptoms As Severe Enough to Consult a Physician. Gastroenterology 2015, Vol. 148, Issue 4, S-298.

Palsson O, Heymen S, Whitehead WE. Abdominal Pain Versus Abdominal Discomfort: Implications for Diagnostic Assessment of Irritable Bowel Syndrome (IBS). United European Gastroenterology Journal October 2014 2 (1) suppl: P0405.

van Tilburg MA, Hyman PE, Walker L, Rouster A, Palsson OS, Kim SM, Whitehead WE. Prevalence of Functional Gastrointestinal Disorders in Infants and Toddlers. J Pediatr. 2014 Dec 31. pii: S0022-3476(14)01114-7. doi: 10.1016/j.jpeds.2014.11.039. [Epub ahead of print] PubMed PMID: 25557967.

Dorn SD, Palsson OS, Woldeghebriel M, Fowler B, McCoy R, Weinberger M, Drossman DA. Development and pilot testing of an integrated, web-based self-management program for irritable bowel syndrome (IBS). Neurogastroenterol Motil. 2015 Jan;27(1):128-34. doi: 10.1111/nmo.12487. Epub 2014 Dec 6. PubMed PMID: 25482042.

Palsson OS, Baggish J, Whitehead WE. Episodic nature of symptoms in irritable bowel syndrome. Am J Gastroenterol. 2014 Sep;109(9):1450-60. doi: 10.1038/ajg.2014.181. Epub 2014 Jul 1. PubMed PMID: 24980882.

Ringel-Kulka T, Goldsmith JR, Carroll IM, Barros SP, Palsson O, Jobin C, Ringel Y. Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study. Aliment Pharmacol Ther. 2014 Jul;40(2):200-7. doi: 10.1111/apt.12800. Epub 2014 May 22. PubMed PMID: 24853043.

Kanazawa M, Palsson OS, van Tilburg MA, Gangarosa LM, Fukudo S, Whitehead WE. Motility response to colonic distention is increased in postinfectious irritable bowel syndrome (PI-IBS). Neurogastroenterol Motil. 2014 May;26(5):696-704. doi: 10.1111/nmo.12318. Epub 2014 Feb 13. PubMed PMID: 24602083.

van Tilburg MA, Palsson OS, Ringel Y, Whitehead WE. Is ginger effective for the treatment of irritable bowel syndrome? A double blind randomized controlled pilot trial. Complement Ther Med. 2014 Feb;22(1):17-20. doi: 10.1016/j.ctim.2013.12.015. Epub 2014 Jan 8. PubMed PMID: 24559811; PubMed Central PMCID: PMC3958926.

Chiarioni G, Palsson OS, Asteria CR, Whitehead WE. Neuromodulation for fecal incontinence: an effective surgical intervention. World J Gastroenterol. 2013 Nov 7;19(41):7048-54. PubMed PMID: 24222947; PubMed Central PMCID: PMC3819539. Heymen S, Palsson O, Kim SM, Twist S, Whitehead WE. Patient Preferences for Terminology Used to Identify Fecal Incontinence. United European Gastroenterology Journal October 2014 2 (1) suppl: P0419.

Whitehead WE, Palsson OS, Kim SM, Twist S. Patient Perspectives for Endpoints in Clinical Trials for Fecal Incontinence. United European Gastroenterology Journal October 2014 2 (1) suppl: P0986.

Palsson O, van Tilburg M, Whitehead WE. The Association of Somatization With Irritable Bowel Syndrome (IBS) and Uninvestigated Dyspepsia in the U.S. General Population. United European Gastroenterology Journal October 2014 2 (1) suppl: P1573.

Palsson O, Heymen S, Whitehead WE. Does Perceived Stigma Affect Healthcare Consulting and Quality of Life in Fecal Incontinence? United European Gastroenterology Journal October 2014 2 (1) suppl: P1574.

Van Tilburg MAL, Hyman PE, Walker LS, Rouster A, Palsson OS, Kim SM, Tack JF, Spiller RC, Tack J, Yang Y, Whitehead WE. Prevalence of Infant/Toddler Functional Gastrointestinal Disorders in the U.S.: Results of a National Community Survey of Mothers. Gastroenterology 2014, Volume 146 , Issue 5, S-420

Van Tilburg MAL, Hyman PE, Walker LS, Rouster A, Palsson OS, Kim SM, Tack JF, Spiller RC, Tack J, Yang Y, Whitehead WE. Functional Dyspepsia in Children: Can We Distinguish Epigastric Pain and Postprandrial Distress? Gastroenterology 2014, Volume 146 , Issue 5 , S-143

Palsson OS, Van Tilburg MA, Spiegel BM, Tack JF, Spiller RC, Walker LS, Yang Y & Whitehead WE. Uninvestigated Dyspepsia in the U.S. General Population: Results From the ROME Normative Gastrointestinal Symptoms Survey (RNGSS). Gastroenterology 2014, Volume 146 , Issue 5 , S-266

Palsson OS, Van Tilburg MA, Spiegel BM, Tack JF, Spiller RC, Walker LS, Yang Y & Whitehead WE. Fecal Incontinence (FI) Prevalence and Associated Gastrointestinal Risk Factors in the U.S. General Population. Gastroenterology 2014,Volume 146 , Issue 5 , S-155

Palsson OS, Van Tilburg MA, Spiegel BM, Tack JF, Spiller RC, Walker LS, Yang Y & Whitehead WE. Irritable Bowel Syndrome (IBS) Prevalence in the U.S. General Population: Results From the Rome Normative Gastrointestinal Symptoms Survey (RNGSS). Gastroenterology 2014, Volume 146 , Issue 5 , S-179

Van Tilburg MAL, Hyman PE, Walker LS, Rouster A, Palsson OS, Kim SM, Tack JF, Spiller RC, Tack J, Yang Y, Whitehead WE. Gastroenterology 2014, Volume 146, Issue 5, S-143 - S-144

Heymen S, Palsson OS, Kim SM, Twist S, Whitehead WE. Patient Preference for Defining Success in Fecal Incontinence Treatment Trials. Gastroenterology 2014, Volume 146 , Issue 5, S-721

Heymen S, Palsson OS, Kim SM, Twist S, Whitehead WE. Patient Preference for What Should Be Included in the Definition of Fecal Incontinence. Gastroenterology 2014, Volume 146 , Issue 5, S-720 - S-721

Faurot KR, Gaylord S, Palsson OS, Garland EL, Mann D, Whitehead WE. Mindfulness Meditation Has Long-Term Therapeutic Benefits in Women With Irritable Bowel Syndrome (IBS): Follow-Up Results From a Randomized Controlled Trial. Gastroenterology 2014, Volume 146 , Issue 5, S-124.

Smith SB, Maixner W, Palsson OS, Van Tilburg MAL, Kanazawa M, Whitehead WE. 584 FKBP5 Gene Is Associated With IBS Diagnosis. Gastroenterology 2014, Volume 146 , Issue 5, S-109.

Keefer L, Taft TH, Kiebles JL, Martinovich Z, Barrett TA, Palsson OS. Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther. 2013 Oct;38(7):761-71. doi: 10.1111/apt.12449. Epub 2013 Aug 19. PubMed PMID: 23957526.

Ramsden CE, Faurot KR, Zamora D, Suchindran CM, Macintosh BA, Gaylord S, Ringel A, Hibbeln JR, Feldstein AE, Mori TA, Barden A, Lynch C, Coble R, Mas E, Palsson O, Barrow DA, Douglas Mann J. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial. Pain. 2013 Jul 22. PubMed PMID: 23886520.

van Tilburg MA, Palsson OS, Whitehead WE. Which psychological factors exacerbate irritable bowel syndrome? Development of a comprehensive model. J Psychosom Res. 2013 Jun;74(6):486-92. PubMed PMID: 23731745; PubMed Central PMCID: PMC3673027.

Markland AD, Palsson O, Goode PS, Burgio KL, Busby-Whitehead J, Whitehead WE. Association of low dietary intake of fiber and liquids with constipation: evidence from the National Health and Nutrition Examination Survey. Am J Gastroenterol. 2013 May;108(5):796-803. PubMed PMID: 23567352.

Palsson OS, Whitehead WE. Psychological treatments in functional gastrointestinal disorders: a primer for the gastroenterologist. Clin Gastroenterol Hepatol. 2013 Mar;11(3):208-16. PubMed PMID: 23103907; PubMed Central PMCID: PMC3591464.

Robinson BL, Matthews CA, Palsson OS, Geller E, Turner M, Parnell B, Crane A, Jannelli M, Wells E, Connolly A, Lin FC, Whitehead WE. Obstetric sphincter injury interacts with diarrhea and urgency to increase the risk of fecal incontinence in women with irritable bowel syndrome. Female Pelvic Med Reconstr Surg. 2013 Jan-Feb;19(1):40-5. PubMed PMID: 23321658.

Palsson OS, Baggish J, Whitehead WE. Symptom Episode Patterns in Irritable Bowel Syndrome (IBS). Gastroenterology 2013, Vol. 144, Issue 5, Supplement 1, Page S-919

Whitehead WE, Palsson OS, Cascade E. Validation of Response Scales for ROME Diagnostic Questionnaire. Gastroenterology 2013, Vol. 144, Issue 5, Supplement 1, Page S-916.

Kanazawa M, Whitehead WE, Palsson OS, Shinosaki M, Okuyama Y, Fukudo S. Comparison of Areement Between Reports of Satisfactory Relief and Global Improvement in Patients With IBS: A Cross-Cultural Study Between the US and Japan. Gastroenterology 2013, Vol. 144, Issue 5, Supplement 1, Pages S-265-S-266.

Shen J, Palsson OS, Van Tilburg MAL. Seasonal Variation in Functional Abdominal Pain Is Associated With Changes in Anxiety, Sleep, Parental Response to Pain, Eating and Exercise. Gastroenterology 2013, Vol. 144, Issue 5, Supplement 1, Pages S-400-S-401.

Ringel T, Van Tilburg MAL, Palsson OS, Thurlow K, Ramsden C, Ringel Y. Food-Specific IgG4 Antibody Titers in Subjects With Food Hypersensitivity. Gastroenterology 2013, Vol. 144, Issue 5, Supplement 1, Page S-928.



MacLean EW, Palsson OS, Turner MJ, Whitehead WE. Development and validation of new disease-specific measures of somatization and comorbidity in IBS. J Psychosom Res. 2012 Nov;73(5):351-5. PubMed PMID: 23062808.

Gaylord SA, Palsson OS, Garland EL, Faurot KR, Mann JD, Whitehead WE. Reply to “A Mindful Way Through IBS: Reducing Abdominal Pain And Improving Quality Of Life”. Gastroenterology 2012 May;142(5): 1450.

Palsson OS, Baggish JS, Turner MJ, Whitehead WE. IBS Patients Show Frequent Fluctuations Between Loose/Watery and Hard/Lumpy Stools: Implications for Treatment. Am J Gastroenterol. 2012 Feb;107(2):286-95

Boregowda SC, Choate RE, Handy R, Palsson OS. Thermodynamic Assessment of Multiple Physiological Stress Responses Using Maxwell Relations. International Journal of Modern Engineering Research, Vol.2, Issue.2, Mar-Apr 2012, 297-302.

Palsson OS, Turner MJ, Baggish JS, Whitehead WE. The Significance of Days with No Stool in Irritable Bowel Syndrome. Gastroenterology 2012, Vol. 142, Issue 5, Supplement 1, Page S-818.

Kanazawa M, Whitehead WE, Palsson OS, Turner MJ, Shnozaki M, Okuyama Y, Fukudo S. Medical Care for Irritable Bowel Syndrome (IBS) in Japan Compared to the U.S. Gastroenterology 2012, Vol. 142, Issue 5, Supplement 1, Page S-10.

Van Tilburg MA, Palsson OS, Whitehead WE. Which Psychological Factors Exacerbate Irritable Bowel Syndrome? Test of a Comprehensive Model. Gastroenterology 2012, Vol. 142, Issue 5, Supplement 1, Page S-10.

Kanazawa M, Palsson OS, Turner MJ, Gangarosa LM, Fukudo S, Whitehead WE. Visceral Pain Sensitivity to Intraluminal Distension in the Rectum is Heightened More Than That in the Descending Colon in Patients with Irritable Bowel Syndrome (IBS). Gastroenterology 2012, Vol. 142, Issue 5, Supplement 1, Page S-704.

Heymen S, Palsson OS, Turner MJ, Whitehead WE. What is the Best Case Definition for Identifying Patients with Chronic Constipation? Gastroenterology 2012, In: AGA (Eds.) Gastroenterology 2012, Vol. 142, Issue 5, Supplement 1, Page S-816.

RingeBl Y, Ringel-Kulka T, Ferrier L, Siddle JP, Palsson OS, Bueno L. Fecal Cysteine Protease Activity in Patients With Irritable Bowel Syndrome -Clinical and Physiological Aspects. Gastroenterology 2012, Vol. 142, Issue 5, Supplement 1, Page S-833.

Ringel-Kulka T, Thurlow K, Siddle JP, Palsson OS, Ringel Y. Over and Under Reporting of Abdominal Pain and Quality-of-Life in Patient and Non-Patients With Functional Bowel Symptoms. Gastroenterology 2012 Vol. 142, Issue 5, Supplement 1, Page S-822

Garland EL, Gaylord SA, Palsson O, Faurot K, Mann JD, Whitehead WE. Therapeutic mechanisms of a mindfulness-based treatment for IBS: Effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations. J Behav Med. 2011 Dec 8. [Epub ahead of print] PMID:22161025.

Whitehead WE, Palsson OS, Gangarosa L, Turner M, Tucker J. Lubiprostone does not influence visceral pain thresholds in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2011 Oct;23(10):944-e400 PMID: 21914041.

Gaylord SA, Palsson OS, Garland EL, Faurot KR, Coble RS, Mann JD, Frey W, Leniek K, Whitehead WE. Mindfulness Training Reduces the Severity of Irritable Bowel Syndrome in Women: Results of a Randomized Controlled Trial. Am J Gastroenterol. 2011 Sep;106(9):1678-88. PMID: 21914041.

Whitehead WE, Palsson OS, Gangarosa L, Turner M, Tucker J. Lubiprostone does not influence visceral pain thresholds in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2011 Oct;23(10):944-950. PMID: 21914041.

Nyrop KA, Grover M, Palsson OS, Heymen S, Palmer MH, Goode PS, Whitehead WE, Busby-Whitehead J. Likelihood of nursing home referral for fecally incontinent elderly patients is influenced by physician views on nursing home care and outpatient management of fecal incontinence. J Am Med Dir Assoc. 2012 May;13(4):350-4. PubMed PMID: 21450249.

Ringel-Kulka T, Palsson OS, Maier D, Carroll I, Galanko JA, Leyer G, Ringel Y. Probiotic Bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Versus Placebo for the Symptoms of Bloating in Patients With Functional Bowel Disorders: A Double-blind Study. J Clin Gastroenterol. 2011 Jul;45(6):518-25.

Shinozaki M, Kanazawa M, Palsson OS, Sagami Y, Endo Y, Hongo M, Drossman DA, Whitehead WE, Fukudo S. Validation of the Japanese version of comorbid conditions questionnaire (CCQ-J) and recent physical symptoms questionnaire (RPSQ-J). Intern Med. 2011;50(5):375-80.

Gaylord S, Palsson OS, Garland E, Faurot K, Coble RS, Mann D, Whitehead WE. Therapeutic Impact of Mindfulness Meditation on Irritable Bowel Syndrome (IBS): Results of a Randomized Controlled Trial. Gastroenterology 2011, 140 ed. 5(suppl1):S-50.

Heymen S, Palsson OS, Gangarosa LM, Girdler S, Whitehead WE. Diffuse Noxious Inhibitory Controls (DNIC) Are Compromised in Patients With Irritable Bowel Syndrome (IBS) Compared to Healthy Controls (HC). Gastroenterology 2011, 140 ed. 5(suppl1):S-538. Heymen S, Palsson OS, Maixner W, Gangarosa LM, Girdler S, Whitehead WE. Temporal Summation in Patients With Irritable Bowel Syndrome (IBS) Compared to Healthy Controls (HC). Gastroenterology 2011, 140 ed. 5(suppl1):S-539.

Kanazawa M, Whitehead WE, Levy RL, Seino S, Tatsuta N, Palsson OS, Turner MJ, Endo Y, Nakai K, Satoh H, Fukudo S. Increased Stomach Aches in Children Are Associated With Parent IBS Status and Maladaptive Parenting in Japan. Gastroenterology 2011, 140 ed. 5(suppl1):S-465.

Markland A, Palsson OS, Goode PS, Burgio K, Busby-Whitehead J, Whitehead WE. Association of low dietary intake of fiber and liquids with constipation: Evidence from the National Health and Examination Survey (NHANES). Gastroenterology 2011, 140 ed. 5(suppl1):S-152.

Palsson OS, Turner MJ, Baggish JS, Whitehead WE. How Good Are Individuals at Predicting Diarrhea Based on Perceived Triggers and Warning Sensations?: A Diary Study. Gastroenterology 2011, 140 ed. 5(suppl1):S-795.

Palsson OS, Turner MJ, Tucker J, Whitehead WE. Is the Effect of Lubiprostone on Clinical Pain Mediated by Decreases in Visceral Pain Sensitivity? Gastroenterology 2011, 140 ed. 5(suppl1):S-3.

Robinson BL, Matthews C, Palsson OS, Geller E, Turner MJ, Parnell B, Crane A, Jannelli M, Wells E, Connolly A, Whitehead WE. Influence of Stool Consistency, Urgency, and Obstetric History on Fecal Incontinence. Gastroenterology 2011, 140 ed. 5(suppl1):S-797.

Tanaka Y, Kanazawa M, Hill CE, Palsson OS, Van Tilburg MA, Turner MJ, Gangarosa LM, Fukudo S, Drossman DA, Whitehead WE. Increased Postprandial Colonic Motility is Associated With Sympathetic Nerve Activity in Patients With Irritable Bowel Syndrome. Gastroenterology 2011, 140 ed. 5(suppl1):S-527.

Van Tilburg MA, Palsson OS, Kanazawa M, Turner MJ, Whitehead WE. Excess Co-Morbidity in IBS: Increased Neural Sensitivity or Response Bias? Gastroenterology 2011, 140 ed. 5(suppl1):S-93.

Wong RK, Van Tilburg MA, Sweat D, Squires M, Palsson OS, Turner MJ, Whitehead WE. Predictive Factors in the Development of Post-Infectious Irritable Bowel Syndrome. Gastroenterology 2011, 140 ed. 5(suppl1):S-527.

Keefer L, Kiebles JL, Kwiatek MA, Palsson OS, Taft TH, Martinovich Z, Barrett TA. The potential role of a self-management intervention for Ulcerative Colitis: A brief report from the Ulcerative Colitis Hypnotherapy Trial. Biological Research for Nursing, in press.

Palsson OS. Hypnosis Treatment for Gut Problems. European Gastroenterology & Hepatology Review, 2010;6(1):42–6.

Palsson, OS. Getting to the heart of cognitive-behavioral therapy effects on non-cardiac chest pain. J Psychosom Res. 2010 Sep;69(3):237-9.

Wong RK, Palsson OS, Turner MJ, Levy RL, Feld AD, von Korff M, Whitehead WE. Inability of the Rome III Criteria to Distinguish Functional Constipation From Constipation-Subtype Irritable Bowel Syndrome. Am J Gastroenterol. 2010 May 25. [Epub ahead of print] PubMed PMID: 20502449.

Dunivan GC, Heymen S, Palsson OS, von Korff M, Turner MJ, Melville JL,Whitehead WE. Fecal incontinence in primary care: prevalence, diagnosis, and health care utilization. Am J Obstet Gynecol. 2010 May;202(5):493.e1-6.

Grover M, Busby-Whitehead J, Palmer MH, Heymen S, Palsson OS, Goode PS, Turner M, Whitehead WE. Survey of geriatricians on the impact of fecal incontinence on nursing home referral. Journal of the American Geriatrics Society 2010 May 7. [Epub ahead of print] PubMed PMID: 20487073

Kanazawa M , Palsson OS, Van Tilburg MAL, Gangarosa LM, Fukudo S, Drossman DA, Whitehead WE. Motility Response to Colonic Distention is Increased in Post-Infectious Irritable Bowel Syndrome (PI-IBS). Gastroenterology 2010;138:S-91.

Palsson OS, Turner MJ, Heymen S, Weinland SR, Tucker J, Keck L, Whitehead WE. Developing a Screening Questionnaire for Visceral Hypersensitivity. Gastroenterology 2010;138: S-144.

Palsson OS, Turner MJ, Baggish JS, Whitehead WE. Anticipating Diarrhea: Triggers, Warnings, and Prevention. Gastroenterology 2010;138:S-382.

Heymen S, Palsson OS, Turner MJ, Tucker J, Palmer MH, Busby-Whitehead J, Whitehead WE. Residents at Continuing Care Residential Centers (CCRC) Who Consult With Their Doctors Regarding the Presence of Fecal Incontinence (FI) Have Significantly Lower Quality of Life (QOL) Scores. Gastroenterology 2010;138:S-542.

Ringel-Kulka T, Maier DM, Palsson OS, Ringel Y. Characterization and Comparison of Patients Versus Non-Patients With Functional Bowel Symptoms in the General Population. Gastroenterology 2010;138:S-384.

Gaylord SA, Whitehead WE, Coble RS, Faurot KR, Palsson OS, Garland EL, Frey W, Mann JD. Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial. BMC Complement Altern Med. 2009 Jul 28;9:24.

Halpert A, Dalton CB, Palsson O, Morris C, Hu Y, Bangdiwala S, Hankins J, Norton N, Drossman DA. Irritable Bowel Syndrome Patients' Ideal Expectations and Recent Experiences with Healthcare Providers: A National Survey. Dig Dis Sci. 2009 Jun 10.

Jones MP, Keefer L, Bratten J, Taft TH, Crowell MD, Levy R, Palsson O. Development and initial validation of a measure of perceived stigma in irritable bowel syndrome. Psychol Health Med. 2009 May;14(3):367-74.

Van Tilburg MA, Chitkara DK, Palsson OS, Levy RL, Whitehead WE. Parental worries and beliefs about abdominal pain. J Pediatr Gastroenterol Nutr. 2009 Mar;48(3):311-7.

KA Nyrop KA, Grover M, Busby-Whitehead J, Palsson OS, Heymen S, Palmer MH, Goode PS, Turner M, Whitehead WE (2009). Physician attributes that influence the decision to refer a patient with fecal incontinence to a nursing home. JAGS Mar; Vol. 57 (Suppl 1): S48.

Busby-Whitehead J, Grover M, Palmer MH, Heymen S, Palsson OS, Goode PS, Turner M, Whitehead WE (2009). Social circumstances influence the decision to refer an elderly patient with fecal incontinence to a nursing home. JAGS Mar; Vol. 57 (Suppl 1): S48.

Palsson OS, Turner MJ, Levy RL, Feld AD, Von Korff M, Whitehead WE. The ROME III Functional Constipation Criteria Miss 80% of Clinical Constipation Cases. Gastroenterology 2009; 136 (Suppl 1):M1233

Miranda A. Van Tilburg, Marsha J. Turner, Olafur S. Palsson, Motoyori Kanazawa, William E. Whitehead. Reduced Symptoms and Visceral Sensitivity Is Related to Menstrual Cycle Changes in IBS. Gastroenterology 2009; 136 (Suppl 1):1056

Grover M, Busby-Whitehead J, Palmer MH, Heymen S, Palsson OS, Goode PS, Turner MJ & Whitehead WE. Survey of Geriatricians on the Impact of Fecal Incontinence on Nursing Home Referral. Gastroenterology 2009; 136 (Suppl 1):S1236

Ringel-Kulka T, Palsson OS, Galanko J, Maier DM & Ringel Y. Clinical and Physiological Effects of Yogurt Drink Containing the Probiotic Bacteria Bifidobacterium lactis Bb12 and Prebiotic Inulin in Subjects with Functional Bowel Symptoms. Gastroenterology 2009; 136 (Suppl 1):1076

Palsson OS, Turner MJ, Baggish JS & Whitehead WE. Defining Episodes of Diarrhea in Irritable Bowel Syndrome (IBS). Gastroenterology 2009; 136 (Suppl 1):M1206

Kanazawa M, Palsson OS, Van Tilburg MA, Turner MJ, Thiwan SIM, Gangarosa LM, Chitkara DK, Fukudo S, Drossman DA & Whitehead WE. A History of Sexual Abuse and Catastrophizing Have An Impact On IBS Symptom Severity That Is Unrelated to Psychological Distress. Gastroenterology 2009; 136 (Suppl 1):763

Hill CE, Palsson OS, Kanazawa M, Turner MJ, Whitehead WE. IBS Patients Show Parasympathetic Dominance in Heart Rate Variability Compared to Healthy Controls. Gastroenterology 2009; 136 (Suppl 1):M1213

Palsson OS, Turner MJ, Baggish JS, Whitehead WE. Characterizing Diarrhea in Irritable Bowel Syndrome (IBS). Gastroenterology 2009; 136 (Suppl 1):M1223

Wong RK, Palsson OS, Turner MJ, Levy RL, Feld AD, Von Korff M, & Whitehead WE. Are Functional Constipation (FC) and Constipation Subtype Irritable Bowel Syndrome (IBS-C) Different Entities When Diagnosed By ROME III Criteria? Gastroenterology 2009; 136 (Suppl 1):M1224

Ringel Y, Carroll IM, Palsson OS & Sartor RB. Substance P and Its Mucosal Receptors - Possible Mediators of Inflammation and Noxious Sensation in Irritable Bowel Syndrome. Gastroenterology 2009; 136 (Suppl 1):S1249

Kanazawa M, Tana C, Watanabe S, Palsson OS Whitehead WE & Fukudo S. High-Sensitive C-Reactive Protein May Be One of Blood Biomarkers for Visceral Hypersensitivity in Irritable Bowel Syndrome (IBS). Gastroenterology 2009; 136 (Suppl 1):W1692

Charioni G., Palsson O.S., Whitehead WE (2008). Hypnosis and upper digestive function and disease. World J Gastroenterol 2008 November 7; 14(41): 6276-6284

Kanazawa M., Palsson O.S., Thiwan S.I., Turner M.J., van Tilburg M.A., Gangarosa L.M., Chitkara D.K., Fukudo S., Drossman D.A., Whitehead W.E. (2008) Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits. Am J Gastroenterol. Oct;103(10):2550-61.

Van Tilburg MA, Palsson OS, Levy RL, Feld AD, Turner MJ, Drossman DA, Whitehead WE. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO. BMC Complement Altern Med. 2008 Jul 24;8:46.

Grover M, Kanazawa M, Palsson OS, Chitkara DK, Gangarosa LM, Drossman DA, Whitehead WE (2008). Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress. Neurogastroenterol Motil. Sep;20(9):998-1008.

Halpert A, Dalton CB, Palsson O, Morris C, Hu Y, Bangdiwala S, Hankins J, Norton N, Drossman DA. (2008) Patient Educational Media Preferences for Information About Irritable BowelSyndrome (IBS). Dig Dis Sci. Dec;53(12):3184-90.

Grover M, Palsson O, Levy R, Feld A, Von Korff M, Whitehead, WE. Chronic constipation: health care consulters vs non-consulters. Neurogastroenterology & Motility 2008; 20 (Suppl. 2): 24-25.

Ringel-Kulka T, Palsson OS, Maier D, Ringel Y. The effect of daily consumption of probiotic bacteria Bifidobacterium lactis BB12 and prebiotic inulin on colonic transit time in subjects with functional bowel symptoms. Neurogastroenterology & Motility 2008; 20 (Suppl. 2): 94.

Bobzien, B, Ringel-Kulka T, Covington M, Palsson OS, Ringel Y. Long-term gastrointestinal symptoms following acute enteric viral infections. Neurogastroenterology & Motility 2008; 20 (Suppl. 2): 137.

Palsson OS, Naliboff BD, Turner MJ, Levy RL, Feld AD, Von Korff M, Whitehead WE. Both Bowel Symptom Severity and Visceral Anxiety are Major Determinants of the Quality of Life Impact of Constipation. Gastroenterology 2008;134(4)Suppl 1:A416

Palsson OS, Turner MJ, Levy RL, Feld AD, Von Korff M, Drossman DA, Whitehead WE. The ROME III Questionnaire Functional Constipation Module as a Constipation Severity Scale. Gastroenterology 2008;134(4)Suppl 1:A421.

Palsson OS, Van Tilburg MA, Kanazawa M, Chitkara DK, Gangarosa LM, Drossman DA, Whitehead WE. Persistence of the Rome Diagnostic Symptoms for Irritable Bowel Syndrome. Gastroenterology 2008;134(4)Suppl 1:A421-22.

Grover M, Kanazawa M, Chitkara DK, Gangarosa LM, Palsson OS, Drossman DA, Turner MJ, Whitehead WE. Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Association with Colon Motility, Bowel Symptoms, and Psychological Distress. Gastroenterology 2008;134(4)Suppl 1:A680.

Heymen S, Palsson OS, Von Korff M, Levy RL, Turner MJ, Whitehead WE. Health Care Costs Associated with Fecal Incontinence. Gastroenterology 2008;134(4)Suppl 1:A279.

Nguyen TV, Palsson OS, Von Korff M, Feld AD, Levy RL, Turner MJ, Whitehead WE. Health Care Costs and Utilization in Patients with Chronic Constipation. Gastroenterology 2008;134(4)Suppl 1:A280.

Ringel Y, Palsson OS, Leyer G, Causey S, Yeskel SE, Faber SM, Ringel-Kulka T. Probiotic bacteria Lactobacillus Acidophilus Ncfm and Bifidobacterium Lactis Bi07 improve symptoms of bloating in patients with functional bowel disorders (FBD). Gastroenterology 2008;134(4)Suppl 1:A549.

Ringel Y, Ringel A, Palsson OS, Kanazawa M, Whitehead WE. Meal Induced Symptoms in Patients with Irritable Bowel Syndrome – Clinical and Physiological Characteristics. Gastroenterology 2008;134(4)Suppl 1:A681.

Whitehead WE, Palsson OS, Levy RR, Feld AD, Turner M, Von Korff M. (2007). Comorbidity in irritable bowel syndrome. Am J Gastroenterol. Dec;102(12):2767-76.

Dorn SD, Palsson OS, Thiwan SIM, Kanazawa M, Clark WC, Van Tilburg MAL, Drossman DA, Scarlett Y, Levy RL, Ringel Y, Crowell MD, Olden KW, Whitehead WE. (2007). Colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity. Gut, 56:1202-1209.

Nyrop KA, Palsson OS, Levy RL, Von Korff M, Feld AD, Turner MJ, Whitehead WE. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhea and functional abdominal pain. Aliment Pharmacol Ther 2007;26:237-48.

Halpert, A., Dalton, C., Hu, Y., Morris, C., Palsson, O., Norton, N., & Drossman, D.A. (2007). What patients know about irritable bowel syndrome (IBS) and what they would like to know: National survey on patient educational needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ). American Journal of Gastroenterology,102:1972-1982.

Kanazawa, M., Drossman, D.A., Shinozaki, M., Sagami, Y., Endo, Y., Palsson, O.S., Hongo, M., Whitehead, W.E., & Fukudo, S. (2007). Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J). BioPsychoSocial Medicine,1:6.

Palsson OS, Turner, MJ, Levy, Feld AD, Von Korff, M, Whitehead, WE. Prevalence and Predictors of Non-Consulting for Chronic Constipation. American Journal of Gastroenterology 2007; 102 Suppl 2: S512.

Nguyen T, Palsson OS, Von Korff M, Feld AD, Levy R, Turner M, Whitehead WE. Satisfaction with Laxatives in Chronic Constipation and Irritable Bowel with Constipation. American Journal of Gastroenterology 2007; 102 Suppl 2: S516-17.

Palsson OS, Van Tilburg MAL, Levy RL, Turner MJ, Chitkara DK, Gangarosa LM, Kanazawa M, Whitehead WE. Excess Medical Diagnoses in Families of Irritable Bowel Syndrome (IBS) Patients. Gastroenterology 2007;132 (4):A520.

Palsson OS, Kanazawa M, Van Tilburg MAL, Thiwan SIM, Ringel Y, Dorn SD, Gangarosa LM, Turner MJ, Drossman DA. Whitehead WE. Determinants of Irritable Bowel Syndrome Severity. Gastroenterology 2007;132 (4):A677-678.

Jones MP, Havlicek T, Keefer L, Bratten J, Norton NJ, Crowell MD, Levy RL, Palsson OS. The Perceived Stigma Scale in IBS: A Preliminary Report on Development and Validation. Gastroenterology 2007;132 (4):A521.

Palsson OS, Ringel Y, Van Tilburg MAL, Gangarosa LM, Turner MJ, Kanazawa M, Thiwan SIM, Drossman DA, Whitehead WE. Impact of Fecal Incontinence on Irritable Bowel Syndrome. Gastroenterology 2007;132 (4):A678.

Kanazawa M, Palsson OS, Thiwan SIM, Turner MJ, Van Tilburg MAL, Fukudo S, Drossman DA, Whitehead WE. Differences in Visceral Hypersensitivity and Hypercontractivity to Intraluminal Distention between Subtypes of Bowel Movement in Irritable Bowel Syndrome (IBS). Gastroenterology 2007;132 (4):A458-459.

Kanazawa M, Palsson OS, Shinozaki M, Sagami Y, Endo Y, Shoji T, Hongo M, Whitehead WE, Fukudo S. Comparison of Comorbidity in Japanese and U.S. Patients with Irritable Bowel Syndrome. Gastroenterology 2007;132 (4):A680-681.

Van Tilburg MAL, Palsson OS, Turner MJ, Chitkara DK, Ulshen M, Whitehead WE. Self Administered Guided Imagery Used at Home is an Effective Treatment for Functional Abdominal Pain in Children. Gastroenterology 2007;132 (4):A59.

Whitehead WE, Palsson OS, Kanazawa M, Gangarosa LM, Thiwan SIM, Drossman DA, Van Tilburg MAL, Chitkara DK, Dorn SD, Ringel Y, Turner MJ, Cluster Analysis Evidence that Irritable Bowel Syndrome is not a Single Disorder but a Collection of Distinct Syndromes. Gastroenterology 2007;132 (4):A148.

Whitehead, W.E., Palsson, O.S., Levy, R.L., Feld, A.D., Von Korff, M., Turner M. (2006). Response to Dr. Allen Mangel's Letter. American Journal of Gastroenterology, 101(12):2885-6.

Palsson, O.S, Whitehead, W.E. (2006) Hypnosis for non-cardiac chest pain. Gut, 55(10):1381-4.

Palsson O. S. (2006). Should we incorporate psychological care into the management of IBS? Nature Clinical Practice Gastroenterology and Hepatology, 3(9):474-5.

Whitehead W. E, Palsson O. S, Feld A. D., Levy R.L;, Von Korff M, Turner M.J, Drossman D. A. Utility of Red Flag Symptom Exclusions in the Diagnosis of Irritable Bowel Syndrome. Alimentary Pharmacology and Therapeutics, 24(1):137-46.

Palsson O.S. & Heymen S. (2006). Treatment of functional anorectal disorders: Biofeedback is proving its value like never before. Biofeedback, 34(1), 20-24.

Whitehead WE, Palsson OS, Levy RL, Feld AD, VonKorff M, Turner M. Reports of "satisfactory relief" by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement. Am J Gastroenterol. 2006 May;101(5):1057-65.

Palsson OS, Turner MJ, Whitehead WE. (2006). Hypnosis home treatment for irritable bowel syndrome: a pilot study. International Journal of Clinical and Experimental Hypnosis, 54(1):85-99.

Palsson OS. (2006). Standardized hypnosis treatment for irritable bowel syndrome: the North Carolina protocol. International Journal of Clinical and Experimental Hypnosis, 54(1):51-64.

Palsson OS. Editor's Preamble: The Nature of IBS and the Need for a Psychological Approach. International Journal of Clinical and Experimental Hypnosis, 54(1):1-6.

Dorn SD, Palsson OS, Thiwan SIM, Kanazawa M, Clark WC, van Tilburg MAL, Drossman DA, Scarlett Y, Levy RL, Ringel Y, Crowell MD, Olden KW, Whitehead WE. Increased colonic sensitivity in irritable bowel syndrome is the result of increased perceptual response bias rather than increased perceptual sensitivity. Gastroenterology 2006;128(4), Suppl 2: A-443.

Kanazawa M, Palsson OS, Thiwan SIM, Turner MJ, van Tilburg M, Crowell MD, Fukudo S, Drossman DA, Whitehead WE. Irritable bowel syndrome (IBS) patients show hyper-reactive motility responses to intraluminal distention which are unrelated to pain hypersensitivity. Gastroenterology 2006, 130(4), Suppl.2;A-290.

Van Tilburg MAL, Palsson OS, Chitkara DK, Whitehead WE. Medical consultation for children's chronic stomachaches is related to a belief that the symptoms have a physical cause but is not related to anxiety about serious missed diagnosis. Gastroenterology 2006;130(4), Suppl.2: A-501.

Van Tilburg MAL, Palsson OS, Whitehead WE. Somatization trait and somatization disorder have different impacts on IBS. Gastroenterology 2006;130(4), Suppl.2: A-503.

Whitehead WE, Palsson OS, Levy RL, Von Korff M, Feld AD, Turner MJ. Symptoms of constipation that predict dissatisfaction with bowel habits. World Congress 2005.

Whitehead WE, Palsson OS, Thiwan SIM, Keku TO, Kanazawa M, Fukudo S, van Tilburg MAL, Peacock J, Barnes J, Turner MJ. Short-allele serotonin transporter gene polymorphism is associated with elevated serotonin and is less common in IBS with constipation compared to healthy controls. Gastroenterology 2006;130(4), Suppl.2: A-513.

Thiwan SIM, Palsson OS, Turner MJ, Whitehead WE. Subjective bloating is not correlated with intestinal gas production but is weakly correlated with abdominal distention. Gastroenterology 2006, 130(4), Suppl.2: A-506.

Thiwan SIM, Palsson OS, Turner MJ, Whitehead WE. Lactose malabsorption, small bowel bacterial overgrowth and celiac disease in IBS patients. Gastroenterology 2006, 130(4), Suppl.2: A-506.

Thiwan SIM, Palsson OS, Turner MJ, Whitehead WE. Elevated breath methane in constipation. Gastroenterology 2006, 130(4), Suppl.2: A-509.

Halpert A, Dalton C, Palsson O, Hu Y, Morris C, Bangdiwala S, Norton N, Drossman D. What patients with irritable bowel syndrome (IBS) expect from their health care providers. National Survey on IBS Educational Needs and Expectations. Gastroenterology 2006, 130(4), Suppl.2: A505.

Palsson O.S, & Drossman D.A. (2005). Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological treatments. Gastroenterology Clinics of North America, 34(2), 281-303.

Palsson, O.S., & Whitehead, W.E. (2005). Comorbidity Associated With Irritable Bowel Syndrome. Psychiatric Annals, 35(4), 320-329.

Van Tilburg, M.A.L., Palsson, O.S., Levy, R.L., Whitehead, W.E. (2005). Parental Worries about Recurrent Abdominal Pain. Journal of Pediatric Gastroenterology and Nutrition, 41 (suppl1), S79.

Palsson, O.S., Levy R.L., Feld, A.D., Von Korff, M., Turner, M.J., & Whitehead, W.E. (2005).
Patient characteristics determining clinical diagnosis of constipation-predominant IBS (IBS-C) vs. chronic constipation (CC). American Journal of Gastroenterology, 100(10), Suppl., S338.

Palsson, O.S., Levy R.L., Feld, A.D., Von Korff, M., Turner, M.J., & Whitehead, W.E. (2005).
Which symptoms predict satisfaction with treatment and improved quality of life in irritable bowel syndrome (IBS)? American Journal of Gastroenterology, 100(10), Suppl., S341-342.

Palsson, O.S., Levy R.L., Feld, A.D., Von Korff, M., Turner, M.J., & Whitehead, W.E. (2005).
Do comorbid dyspepsia and reflux symptoms affect morbidity, utilization, and outcome in irritable bowel syndrome? American Journal of Gastroenterology, 100(10), Suppl., S338.

Palsson, O.S., Levy R.L., Feld, A.D., Von Korff, M., Turner, M.J., & Whitehead, W.E. (2005).
Which medications and food supplements are associated with bloating in patients with functional bowel disorders? American Journal of Gastroenterology, 100(10), Suppl., S338-339.

Palsson, O.S., Levy R.L., Feld, A.D., Von Korff, M., Turner, M.J., & Whitehead, W.E. (2005).
Why Do Irritable Bowel Syndrome Patients Take Multiple Drugs And What Are The Associated Costs? American Journal of Gastroenterology, 100(10), Suppl., S

Kanasawa, M, Drossman, D.A., Shinozaki, M., Sagami, Y., Endo, Y., Palsson, O.S., Hongo, M., & Whitehead, W.E. (2005) Translation and validation of a Japanese version of the Irritable Bowel Syndrome-Quality of Life Measure (IBS-QOL-J). American Journal of Gastroenterology, 100(10), Suppl., S334.

Halpert, A., Dalton, C., Hu, Y., Morris, C., Palsson, O., Norton, N., & Drossman, D.A. (2005). National survey on patient education in irritable bowel syndrome (IBS). American Journal of Gastroenterology, 100(10), Suppl., S336.

Whitehead WE, Palsson OS, Levy RL, von Korff M, Feld AD, Drossman DA, Turner MJ. Serious misclassifications (gastrointestinal cancer, IBD, or malabsorption) are infrequent in patients with a clinical diagnosis of IBS. Gastroenterology 2005;128:A463.

Thiwan S, Palsson OS, Turner MJ, Whitehead WE. Responsiveness of the bloating severity Questionnaire (BLSQ). Gastroenterology 2005;128:A462.

Palsson OS, Levy RL, Von Korff M, Feld AD, Barghout V, Turner MJ, Whitehead WE. Over the-counter (OTC) and complementary /alternative medicine (CAM) expenses of irritable bowel syndrome (IBS) patients. Gastroenterology 2005;128:A461.

Thiwan S, Palsson OS, Turner MJ, Whitehead WE. What is the optimal response scale on a questionnaire to elicit the subject's responses to the ROME II criteria for IBS? Gastroenterology 2005;128:A461.

Whitehead WE, Palsson OS, Levy RL, Von Korff M, Feld AD, Drossman DA, Turner MJ. Sensitivity and specificity of red flags for identifying gastrointestinal cancer, IBD, or malabsorption in patients with a functional gastrointestinal disorder (FGID). Gastroenterology 2005;128:A462.

Palsson, O.S., Morteau, O., Bozymski, E.M., Woosley, J.T., Sartor, R.B., & Whitehead, W.E. (2004). Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome. Digestive Diseases and Sciences, 49 (7-8): 1236-1243

Palsson, O.S., Heymen, S., & Whitehead, W.E. (2004). Biofeedback treatment for functional anorectal disorders: A comprehensive efficacy review. Applied Psychophysiology and Biofeedback, 29(3):153-174.

Palsson, O.S. (2004). Psychological treatments for functional gastrointestinal disorders: Current status. Functional Brain-Gut Newsletter, 32, 16-38.

Whitehead W.E, Levy R., Von Korff M., Feld A., Palsson O.S., Turner M.J., Drossman, D.A. (2004). Usual medical care for irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, Dec;20(11-12):1305-15.

Palsson OS, Whitehead WE, Levy RL, Feld AD, Von Korff M, Turner MJ. (2004) Constipation less effectively treated than other functional bowel problems in a health maintenance organization (HMO). American Journal of Gastroenterology, 99(10) Suppl:S287.

Palsson, O.S., Thiwan, S.M., Whitehead, W.E. & Turner, M.J. (2004). Development of a bloating severity questionnaire. American Journal of Gastroenterology, 99(10) Suppl:S286.

Thiwan, S.M., Palsson, O.S., Whitehead, W.E. & Turner, M.J. (2004). Assessing the sensitivity of the bloating severity questionnaire (BLSQ). American Journal of Gastroenterology, 99(10) Suppl:S286-S287.

Whitehead, W.E., Levy R.L., Von Korff, M., Feld, A.D., Palsson, O.S. (2004). Workup for first-time consulters costs less than continuing care for IBS. American Journal of Gastroenterology, 99(10) Suppl:S239.

Whitehead, W.E., Levy R.L., Von Korff, M., Feld, A.D., Kahler, K., Barghout, V. & Palsson, O.S. (2004). Relationship between satisfaction with treatment outcome and cost in IBS patients. American Journal of Gastroenterology,99(10) Suppl:S239.

Whitehead, W.E., Palsson, O.S., Levy, R.L., Feld, A.D., Von Korff M, Turner M.J., Drossman, D.A., & Crowell, M.D. (2004). Identification of irritable bowel (IBS) patients with alternating bowel habits. Gastroenterology, 126(4), Suppl 2: A-369.

Van Tilburg, M.A.L., Venepalli, N., Palsson, O.S., Whitehead, W.E. (2004). The parental worries of recurrent abdominal pain questionnaire: Do parental cognitions distinguish consulters from non-consulters? Gastroenterology, 126(4), Suppl 2: A-372.

Palsson, O.S., Whitehead, W.E., Levy, R.L., Feld, A.D., Dennis, E.H., Barghout, V.E. & Turner, M.J. (2004). Constipation is often undiagnosed or misdiagnosed in outpatient clinics: diagnosis of constipation is associated with better outcomes. Gastroenterology, 126(4), Suppl 2: A-606.

Palsson, O.S., Whitehead, W.E., Barghout, W.E., Turner, M.J. (2004). Medical diagnoses in functional dyspepsia patients. Gastroenterology, 126(4), Suppl 2: A-604.

Whitehead, W.E., Palsson, O.S., Levy, R.L., Feld A. D., Von Korff, M, Shetzline, M., Turner, M.J. (2004). Types of medications used for irritable bowel syndrome (IBS). Gastroenterology, 126(4), Suppl 2: A-642.

Whitehead, W.E., Palsson, O.S., Levy, R.L., Feld, A.D., Von Korff, M & Turner, M.J., (2004). "Satisfactory relief" is an unsatisfactory method of defining an irritable bowel syndrome (IBS) responder. Gastroenterology, 126(4), Suppl 2: A-88.

Whitehead, W.E., Palsson, O.S., Levy, R.L., Feld, A.D., Von Korff, M, & Turner, M.J. (2004). Psychological symptoms do not predict symptom improvement in standard medical care for irritable bowel syndrome (IBS). Gastroenterology, 126(4), Suppl 2: A-88.

Moss, D., Sella, G. E., Andrasik, F., Donaldson, S., Lehrer, P., Palsson, O., Peper, E., & Sterman, M. B. (2003). Current applications of biofeedback to physical medicine and rehabilitation. Europa Medicophysica, 39, 165-170.

Whitehead, W.E., M.A.L. Tilburg, & Palsson, O.S. (2003). Development of the parental worries of recurrent abdominal pain questionnaire. American Journal of Gastroenterology, 98:S273.

Whitehead, W.E., Palsson, O.S., Barghout, V.E., & Turner, M.J. (2003). Mechanism of diagnosis and frequency of endoscopy in functional dyspepsia. American Journal of Gastroenterology, 98:S303.

Whitehead, W.E., Palsson, O.S., Levy, R.L., Von Korff, M., Feld, A.D., Garner, M. (2003). What constitutes standard medical care for irritable bowel syndrome (IBS) in U.S. primary care and gastroenterology clinics? American Journal of Gastroenterology, 98:S272-S273.

Palsson, O.S., Whitehead, W.E., & Turner, M.J. (2003). Hypnosis home treatment for irritable bowel syndrome: Exploratory study. American Journal of Gastroenterology, 98:S274.

Palsson, O.S., Whitehead, W.E., Barghout, V., Levy R.L., Feld, A.D., Von Korff, M., Garner M., Drossman, D.A., & Turner, M.J. (2003). IBS severity and health-related quality of life improve with age in women but not in men. American Journal of Gastroenterology, 98:S272.

Palsson, O.S., Turner, M.J., van Tilburg M.A.L., Kanasawa M., Whitehead, W.E. (2003). Survey of the effects of changes in female sex hormones on irritable bowel syndrome. Gastroenterology, 124 (Suppl 1): A396.

Palsson, O.S., Levy R.L.., Von Korff, M., Feld A., Turner M.J., & Whitehead, W.E. (2003). Comorbidity and psychological distress in irritable bowel syndrome (IBS). Gastroenterology, 124 (Suppl 1): A388.

Whitehead, W.E., Palsson, O.S., Levy R.L., Feld A.D., Von Korff, M., Drossman, D.A. & Turner, M.J. (2003). Agreement of Rome criteria with clinical diagnosis of irritable bowel (IBS). Gastroenterology, 124 (Suppl 1): A397.

Palsson, O.S., Levy R.L., Von Korff, M., Feld A.D., Turner M.J. & Whitehead., W.E. (2003). Alternative medicine and home remedy use in irritable bowel syndrome (IBS) is related to bloating and diarrhea. Gastroenterology, 124 (Suppl 1): A391.

Whitehead, W.E., Palsson, O.S., Von Korff, M., Levy R.L., Feld A.D., Turner M.J. (2003). Excess comorbidity in irritable bowel syndrome is related to hypervigilance. Gastroenterology, 124 (Suppl 1): A391.

Feld A.D., Von Korff, M., Levy R. L.., Palsson, O.S., Turner M.J. & Whitehead, W. E. (2003). Excess surgery in irritable bowel syndrome (IBS). Gastroenterology, 124 (Suppl 1): A388.

Whitehead, W.E., Palsson, O.S., Levy R.L., Von Korff, M., Feld, A.D., & Turner, M.J. (2003).
Comorbid psychiatric disorders in irritable bowel (IBS) and inflammatory bowel disease (IBD). Gastroenterology, 124 (Suppl 1): A398.

Palsson, O.S. (Summer, 2003). Resul
ts of a national survey of the effects of changes in female sex hormones on irritable bowel syndrome. Digest, Newsletter of the UNC Center for Functional GI and Motility Disorders, 1-6.

Palsson, O.S. & Whitehead, W.E. (2002). The growing case for hypnotherapy as adjunctive therapy for functional gastrointestinal disorders. Gastroenterology, 123(6):2132-2147. Editorial.

Palsson, O.S., Turner, M.J., Johnson, D.A., Burnett, C.K., & Whitehead, W.E. (2002). Hypnosis treatment of severe irritable bowel syndrome: Investigation of mechanism and effects on symptoms. Digestive Diseases and Sciences, 47(11): 2605-2614.

Palsson, O.S. & Pope, A.T. (2002). Morphing beyond recognition: The future of biofeedback technologies. Biofeedback, 14(30), 14-18.

Whitehead, W.E., Palsson, O.S. & Jones, K.R. (2002). Systematic review of the comorbidity of irritable bowel syndrome with other somatic disorders: What are the causes and implications? Gastroenterology, 122(4):1140-56. Review.

Palsson, O.S. (2002) Hypnosis treatment of irritable bowel syndrome. Participate, Newsletter of the International Foundation for Functional Gastrointestinal Disorders, 11(3), 4-6.

Whitehead, W.E. & Palsson, O.S. (in press). Treatment of functional gastrointestinal disorders: Advantages of a combined medical-psychiatric approach. Journal of Psychosomatic Research.

Palsson, O.S. Irritable bowel syndrome and quality of life (Fall 2002). Digest, Newsletter of the UNC Center for Functional GI and Motility Disorders, 8-11.

Palsson, O.S., Jones K.R., Turner M.J., Drossman D.A., & Whitehead, W.E. (2002). Development of specific questionnaires to assess somatization and comorbid diagnoses in irritable bowel syndrome (IBS). Gastroenterology, 122 (Suppl 1): A502.

Palsson, O.S., Jones K.R., Turner M.J., Drossman D.A., & Whitehead, W.E. (2002). Impact of somatization and comorbid medical conditions on health care utilization, disability, and quality of life in irritable bowel syndrome (IBS). Gastroenterology, 122 (Suppl 1): A501-502.

Whitehead, W.E., Palsson, O.S., Jones K.R., Turner M.J., Drossman D.A. (2002). Role of parental modeling in somatization of adults with irritable bowel syndrome. Gastroenterology, 122 (Suppl 1) A502.

Palsson, O.S., Turner, M.J., Davies, M.J., Johnson, D.A., & Whitehead, W.E. (2001). Vasoactive intestinal peptide levels are elevated in the blood plasma of irritable bowel syndrome (IBS) patients. Gastroenterology, 120 (Suppl 1); A718-A719.

Jones, K.R., Palsson, O.S. Levy, R.L, Feld A. J., Longstreth, G.F. , Bradshaw, B. H., Drossman, D.A., & Whitehead, W.E. (2001). Somatization in irritable bowel syndrome. Gastroenterology, 120 (Suppl 1); A639.

Jones, K.R., Palsson, O.S. Levy, R.L, Feld A. J., Longstreth, G.F. , Bradshaw, B. H., Drossman, D.A., & Whitehead, W.E. (2001). Comorbid disorders and symptoms in irritable bowel syndrome (IBS) Compared to other gastroenterology patients. Gastroenterology, 120, A66.

Levy, R.L, Whitehead, W.E., Feld, A.D, Longstreth, G.F., Palsson, O.S., Jones, K.R. (2001). Psychological symptoms correlate with abdominal pain more in females than in males. Gastroenterology, 120, A639-640.

Palsson, O.S., Turner, M.J., & Johnson, D.A. (2000). Hypnotherapy for irritable bowel syndrome: Symptom improvement and autonomic nervous system effects. Gastroenterology, 118,(4), A174.

Palsson, O.S., Turner, M.J., & Johnson, D.A. (2000). Psychological threat perception and symptom severity in patients with irritable bowel syndrome. Gastroenterology, 118 (4), A617.

Palsson, O.S., & Nussen, J. (2000). Quantitative electroencephalographic (QEEG) activity, health history and emotional distress. Proceedings of the 31st Annual Meeting of the Association for Applied Psychophysiology and Biofeedback, Denver, CO, 83-86.

Palsson, O.S. & Davies, T.C. (1999). Behavioral health services providers in primary care: Innovative models of health care and service delivery. Biofeedback, 27(1),14-20.

Palsson, O.S., & Reavis, S.L. (2000). Psychological traits modulating threat perception and immune system. Proceedings of the 31st Annual Meeting of the Association for Applied Psychophysiology and Biofeedback, Denver, CO, 87-90.

Palsson,O.S. (1999). Altered visceral perception in irritable bowel syndrome. Practical Gastroenterology, 23(3), 52-63.

Palsson, O.S. (1999). The role of visceral hypersensitivity in IBS has not been established: A response to Dr. Quigley's article. Practical Gastroenterology, 23(3), 51.

Palsson, O.S. & Davies, S.M. (1999). Building mind-body bridges in medical school: A model. Biofeedback, 27(1), 21-23.

Boregowda, S.C., Tiwari, S.N., Palsson, O.S., & Downing, B.K. (1999). Measuring the effects of information processing on psychophysiological stress responses. Proceedings of the 37th AIAA Aerospace Sciences Meeting. Reno, Nevada, AIAA paper no. 99-0980.

Whitehead, W.E., & Palsson, O.S. (1998). Is rectal sensitivity a biological marker for irritable bowel syndrome: Psychological influences on pain perception in irritable bowel syndrome. Gastroenterology, 115 (5), 1263-1271.

Whitehead, W.E., Crowell, M.D., Davidoff, A.L., Palsson, O.S., & Schuster, M.M. (1997). Pain from rectal distension in women with irritable bowel syndrome: Relationship to sexual abuse. Digestive Diseases and Sciences, 42(4), 796-804.

Palsson, O.S. (1996). Soothing the gut with hypnosis. Virginia Hypnosis Society Newsletter, 5(1), 5.

Palsson, O.S. (Spring 1996). The high risk model of threat perception as a framework for the development of treatments for psychophysiological disorders. Biofeedback,24(1),14-17.

Palsson, O.S. (1994). The utilization of hypnosis in dentistry. Hardjaxl, Journal of the Icelandic Dental Students Association, 30, 39-42.

Whitehead,W.E., Forneris, C.A.,.Morris, R.L., Hanna, B., Perkins, M.H., Cook, E. III, Palsson, O.S., Drossman, D.A., & Taub, E. (in press). Development of a questionnaire to identify patients meeting Rome criteria for functional gastrointestinal disorders. Gastroenterology.

Gibbs, N.A., Palsson, O.S., Levy R.L., Meyer K., & Whitehead, W.E. (under review). Patients with irritable bowel syndrome pay selective attention to gastrointestinal sensations.

Palsson, O.S., McCommons, J.J., Burnett, C.K., Bradley, L.A., & Whitehead, W.E. (under review). Relationship between rectal pain, urge to defecate and fullness in irritable bowel syndrome patients and healthy subjects.

Boregowda, S.C., Tiwari S. N., Chaturwedi S. K., & Palsson, O.S. (1997). An innovative approach to measuring and monitoring human stress levels in man/machine interactions. Proceedings of the 18th National Conference of the American Society of Engineering Management. Virginia Beach, VA.

Palsson, O.S., & Downing, B.K. (1999). Psychophysiological characteristics of patients with irritable bowel syndrome". Applied Psychophysiology and Biofeedback.

Palsson, O.S., & Downing, B.K. (1999). Gender matters: Psychophysiological data on ninety healthy men and women. Applied Psychophysiology and Biofeedback.

Palsson, O.S., Davies, S.M., & Downing, B.K. (1998). Psychological modulators of cardiovascular reactions to cognitive stress. Applied Psychophysiology and Biofeedback, 23 (2), 108.

Palsson, O.S., Boregowda, S.C., & Downing, B.K. (1998). The relationship between the Objective Stress Index (OSI) and stress-related physical symptoms. Applied Psychophysiology and Biofeedback, 23 (2), 125.

Whitehead, W.E., Palsson, O.S., Levy RL, Gibbs NA, Meyer KB. (1998). Patients with irritable bowel syndrome pay selective attention to gastrointestinal sensations. Gastroenterology, 114, A859.

Whitehead, W.E., Burnett, C.E., Palsson, O.S., & Drossman, D.E. (1998). Can symptoms distinguish subtypes of constipation? Gastroenterology, 114, A729.

Burnett, C, Palsson, O, Whitehead, W.E., & Drossman, D. (1998). Psychological distress and impaired quality of life in patients with functional anorectal disorders. Gastroenterology, 114, A859.

Boregowda, S.C., Palsson, O.S., Tiwari, S.N, & Bartolome-Rull, D.S. (1998). Thermodynamic approach to quantify human stress levels using an Objective Stress Index (OSI). Applied Psychophysiology and Biofeedback, 23 (2), 110-111.

Palsson, O.S., Burnett, C.K., Meyer, K., and Whitehead, W.E. (1997). Hypnosis treatment for irritable bowel syndrome. Effects on symptoms, pain threshold and muscle tone. Gastroenterology;112:A803

Palsson, O.S., Wickramasekera, I.E., Rutledge, C., Davies, M., & Downing, B. (1997). Social desirability, repression, and finger temperature. Applied Psychophysiology and Biofeedback;22(2):143.

Palsson, O.S., Taub, E., Cook III, E.C., Burnett, C.K., McCommons, J.J., & Whitehead, WE (1996). Validation of Rome criteria for functional gastrointestinal disorders by factor analysis. American Journal of Gastroenterology, 91(9), 2000.

Palsson, O.S., Morteau, O., McCommons, J.J., Bozymski, E.M., Woosley, J.T., Sartor, R.B., & Whitehead, W.E. (1996). Vasoactive intestinal peptide is elevated in irritable bowel syndrome. Gastroenterology, 109;A730.

Palsson, O.S., Davidoff, A., Crowell, M.D., Burnett, C.K., & Whitehead, W.E. (1996). Psychological functioning in irritable bowel syndrome: Role of sexual abuse history. Gastroenterology; 109;A729.

Palsson, O.S., Morteau, O., McCommons, J.J., Bozymski, E.M., Woosley, J.T., Sartor, R.B., & Whitehead, W.E. (1996). Is mucosal inflammation present in irritable bowel syndrome? Gastroenterology, 109;A730.

Palsson, O.S., McCommons, J.J., Burnett, C.K., Bradley, L.A., & Whitehead, W.E. (1995). Relationship between bowel sensations: Pain, urge to defecate and rectal fullness in irritable bowel syndrome (IBS) patients and healthy subjects. Gastroenterology, 108; A663.

Palsson, O.S., Wickramasekera, I.E., & Pope, A. (Spring 1993). The psychological and psychophysiological effects of stress reduction via group hypnosis. Psychological Hypnosis Bulletin.

Wickramasekera, I. & Palsson, O.S. (1991). Pilot study of psychological and physiological responses to exposure to pictures of dead bodies and body parts. Proceedings of the 22nd Annual Meeting of the Association for Applied Psychophysiology and Biofeedback, 327-328.

Oral presentations at national scientific meetings

May 5, 2010. Developing a Screening Questionnaire for Visceral Hypersensitivity. Presentation at Digestive Disease Week. New Orleans, Luisiana.

March 2008. Lessons from the Gut. Invited presentation at the Annual Meeting of the American Society of Clinical Hypnosis, Chicago, IL.

May 23, 2006. Coexistence of functional gastrointestinal disorders with other chronic visceral and somatic conditions. Symposium presentation at the Annual Meeting of the American Gastroenterological Association. Los Angeles, CA.

March 25, 2006. Hypnosis for gut problems: What we know, and future directions. Invited presentation at the Annual Meeting of the American Society of Clinical Hypnosis, Orlando, FL.

May 17, 2005. Education and reassurance affect satisfaction with care, health care utilization and clinical outcomes among new functional bowel disorder (FBD) patients. Authors: Palsson OS, Levy RL, Von Korff, M, Feld AD, Turner MJ, Whitehead WE. Paper presented at the Annual Meeting of the American Gastroenterological Association. May 17, 2005, Chicago IL.

April 21, 2005. Biofeedback for Pelvic Floor Disorders and Incontinence. Presentation in a full-day Science Forum on "Mind-Body Medicine: Improving Our Health and Performance". Washington, DC.

March 9, 2005. Psychological treatments for functional gastrointestinal disorders. Presentation at the Sixth International Symposium for Functional Gastrointestinal Disorders. Milwaukee, Wisconsin.

May 18, 2004. Psychological symptoms do not predict symptom improvement in standard medical care for irritable bowel syndrome. Research Forum presentation at the Annual Meeting of the American Gastroenterological Association. New Orleans, MO.

March 28, 2003. Functional gastrointestinal disorders in primary care. Symposium presentation at the 34th Annual Meeting of the Association for Applied Psychophysiology and Biofeedback. Jacksonville, FL.

March 28, 2003. The coming dissemination of biofeedback into society. Symposium presentation at the 34th Annual Meeting of the Association for Applied Psychophysiology and Biofeedback. Jacksonville, FL.

March 22, 2002. Physiological findings on the High Risk Model of Threat Perception. Symposium Presentation at the 33rd Annual Meeting of the Association for Applied Psychophysiology and Biofeedback, Las Vegas, NV.

March 31, 2001. Neurofeedback videogame ADHD technology: Results of the first concept study. Presentation in a symposium titled "The future of biofeedback: Fun and games?" at the 32nd Annual Meeting of Association for Applied Psychophysiology and Biofeedback, Raleigh, NC.

March 30, 2001. Treatment of a patient with irritable bowel syndrome, TMJ, headaces and back pain. Symposium presentation at the 32nd Annual Meeting of Association for Applied Psychophysiology and Biofeedback, Raleigh, NC.

March 24, 2001. Hypnosis treatment for irritable bowel syndrome: Research on efficacy and mechanism. Symposium presentation at the 43rd Annual Meeting of the American Society for Clinical Hypnosis. Reno, Nevada.

March 24, 2001. Hypnosis treatment for irritable bowel syndrome: Research on efficacy and mechanism. Presentation in a symposium at the 43rd Annual Meeting of the American Society for Clinical Hypnosis. Reno, Nevada.

August 2000. Absorption and immune system competence. Paper to be presented at the 108th Annual Convention of the American Psychological Association, Washington, D.C. Co-author: Stephanie L. Reavis, B.S.

August 2000. Humor in cinema as hypnosis. Paper presented at the 108th Annual Convention of the American Psychological Association, Washington, D.C. Co-author: Marcia E. Walker, M.A.

August 2000. Physiological findings relating to the High Risk Model of Threat Perception. Paper presented at the 108th Annual Convention of the American Psychological Association, Washington, D.C.

May 21, 2000. Hypnotherapy for irritable bowel syndrome: Symptom improvement and autonomic nervous system effects. Research Forum presentation, Annual Meeting of the American Gastroenterological Association, San Diego, CA.

March 31,2000. The EVMS Protocol: Automated and norm-referenced psychophysiological assessment. Paper to be presented in a symposium titled "Psychophysiological profiling: A basic tool in clinical practice" at the 31st Annual Meeting of the Association for Applied Psychophysiology and Biofeedback, Denver, CO.

April 1, 2000. Quantitative electroencephalographic (QEEG) activity, health history and emotional distress. Paper presented at the 31st Annual Meeting of the Association for Applied Psychophysiology and Biofeedback, Denver, CO. Co-author: Jana Nussen, M.A.

April 2, 2000. Psychological traits modulating threat perception and immune system competence. Citation award paper presented at the 31st Annual Meeting of the Association for Applied Psychophysiology and Biofeedback, Denver, CO. Stephanie L. Reavis, M.S.

February, 2000. "Frontiers of hypnosis and psychosomatic medicine". Keynote address, Annual Meeting of the American Society of Clinical Hypnosis. Baltimore, MD.

June 28, 1999. "Thermal biofeedback: Clinical applications and potential for aviation safety". Invited paper presented at the 33rd Annual Thermophysics Conference of the American Institute of Aeronautics and Astronautics. Norfolk, VA.

April 10, 1999. "Psychophysiological characteristics of patients with irritable bowel syndrome". Paper presented at the 30th Annual Meeting of the Association for Applied Psychophysiology and Biofeedback. Vancouver, Canada.

April 10, 1999. "Gender matters: Psychophysiological data from ninety healthy men and women". Citation award paper presented at the 30th Annual Meeting of the Association for Applied Psychophysiology and Biofeedback. Vancouver, Canada.

April 10, 1999. "Stress counter-response training of pilots via instrument functionality feedback". Paper presented at the 30th Annual Meeting of the Association for Applied Psychophysiology and Biofeedback in a symposium titled "New methods in biofeedback delivery: NASA innovations from aerospace to inner space". Vancouver, Canada.

April 10, 1999. "New ways to deliver biofeedback". Paper presented at the 30th Annual Meeting of the Association for Applied Psychophysiology and Biofeedback in a symposium titled "New methods in biofeedback delivery: NASA innovations from aerospace to inner space". Vancouver, Canada.

August 18, 1998. "Effects of absorption on subjective and objective physical stress". Paper presented at the 106th Annual Convention of the American Psychological Association. San Francisco, CA. Co-Author: Brenda Downing, M.S.

August 18, 1998. "Hypnosis and the gastrointestinal tract". Paper presented at the 106th Annual Convention of the American Psychological Association. San Francisco, CA.

April 5, 1998. Psychological modulators of cardiovascular reactions to cognitive stress.
Award paper presentation at the 29th Annual Meeting of the Association for Applied Psychophysiology and Biofeedback. Orlando, Florida. Co-Authors: S. Margaret Davies and Brenda K. Downing, M.S.

April 4, 1998. "When slow is low: Low theta brainwave amplitudes and physical stress symptoms". Paper presented in a symposium titled "Spirit, Mind, Healing, and the EEG" at the 29th Annual Meeting of the Association for Applied Psychophysiology and Biofeedback. Orlando, Florida. Co-authors: Ian Wickramasekera, Ph.D., and Brenda Downing, M.S.

April 4, 1998. "Effective management of chronic irritable bowel syndrome in primary care patients". Presentation in a symposium titled "Applied Psychophysiology in Primary Care", at the 29th Annual Meeting of the Association for Applied Psychophysiology and Biofeedback. Orlando, Florida.

April 2, 1998. The relationship between an Objective Stress Index (OSI) and stress-related physical symptoms. Presentation in the "Speaker's Corner" program section at the 29th Annual Meeting of the Association for Applied Psychophysiology and Biofeedback. Orlando, Florida. Co-authors: Satish C. Boregowda, M.E., and Brenda K. Downing, M.S.

May 13, 1997. "Hypnosis treatment for irritable bowel syndrome. Effects on symptoms, pain threshold, and muscle tone". Research forum presentation at the Annual Meeting of the American Gastroenterological Association. Washington, DC.

Aug. 1996. "Somatization and psychosocial characteristics in irritable bowel
syndrome patients". Paper presented in a symposium titled "Somatization and psychosocial factors in medical patients". 104th Annual Convention of the American Psychological Association, Toronto, Canada.

Aug. 1996. "The psychophysiological effects of hypnosis treatment for irritable bowel syndrome". Paper presented
in a symposium titled "The psychophysiology of the hypnotic response: Results from hardcore experiments". 104th Annual Convention of the American Psychological Association, Toronto, Canada.

May 17, 1995. "Relationship between bowel sensations: Pain, urge to defecate and rectal fullness in irritable bowel syndrome (IBS) patients and healthy subjects". Research forum presentation at the Annual Meeting of the American Gastroenterological Association. San Diego, California.

March 7, 1994. "A comparative study of stress risk and psychophysiology in patients in a behavioral medicine clinic and college students under stress". Symposium presentation at the 24th Annual Meeting of the Association for Applied Psychophysiology and Biofeedback. Atlanta, Georgia.

March 27, 1993. "Psychophysiological effects in a study of stress-reduction hypnosis". Symposium presentation at the 24th Annual Meeting of the Association for Applied Psychophysiology and Biofeedback. Los Angeles, California.

Workshops and courses for health professionals

April 2, 2005. "Treating refractory IBS". Group discussion leader, break-out session at the UNC Annual Update in Gastroenterology and Hepatology, Chapel Hill, North Carolina.

November 11-14, 2004. Hypnosis Treatment for Functional Gastrointestinal Disorders. A 3½ day course for health professionals, Research Triangle Park, NC. Instructor and course director.

October 10, 2003. Non-Pharmacologic Treatments for Irritable Bowel Syndrome. A 3-hour seminar for the North Carolina Biofeedback Society. Chapel Hill, NC.

April 7, 2003. Treating gastrointestinal disorders with hypnosis. Advanced one-day workshop, 45rd Annual Meeting of the American Society for Clinical Hypnosis. Alexandria, Virginia.

January 25-26, 2002. Trauma, Fear and Loss and in a Troubled Times. Two-day advanced regional hypnosis workshop by the American Society for Clinical Hypnosis. Charlotte, North Carolina. Workshop Chair: Claire Frederick, M.D.

March 25, 2001. Treating gastrointestinal disorders with hypnosis. Advanced one- day workshop, 43rd Annual Meeting of the American Society for Clinical Hypnosis. Reno, Nevada.

October 2000. How to interface applied psychophysiology, biofeedback, and psychotherapy in primary care medicine and complementary medicine settings. Three day continuing education workshop sponsored by the Association of Applied Psychophysiology. Workshop director: Ian E. Wickramasekera, Ph.D.

June, 2000. Introduction to medical uses of hypnosis. A 2 ½ hour continuing education workshop for family physicians. Annual Family Medicine Review Course, Virginia Beach, Virginia. Co-presenter: S. Margaret Davies, M.D.

March 31, 2000. Achieving effective detection, diagnosis and intervention for common psychosocial and psychophysiologic problems in primary care. A half-day workshop to be presented at the 31st Annual Meeting of the Association for Applied Psychophysiology and Biofeedback, Denver, CO. Co-Presenter: S. Margaret Davies, M.D.

October 8-10, 1999. Introductory training course in clinical hypnosis. A 20-hour training course for health professionals presented by the Virginia Hypnosis Society and approved by the American Society for Clinical Hypnosis. Norfolk, Virginia. Co-presenters: Vicki Caminer, Psy.D., Richard Griffin, Psy.D., Donald Lynch, M.D., Alan T. Pope, Ph.D.

September 21-25, 1999. How to interface applied psychophysiology, biofeedback, and psychotherapy in primary care medicine and complementary medicine settings. Three day continuing education workshop sponsored by the Association of Applied Psychophysiology and Biofeedback. Marco Island, FL. Co-instructors: Ian E. Wickramasekera, Ph.D., Terence C. Davies, M.D., Steven Baskin, Ph.D., John Arena, Ph.D., Alan Glaros, Ph.D.

June 9, 1999. "The most common DSM-IV problems in primary care: Effective diagnosis and intervention. A 2 ½ hour continuing education workshop for family physicians. Annual Family Medicine Review Course, Virginia Beach, Virginia. Co-presenter: S. Margaret Davies, M.D.

November 6, 1998. Introduction to clinical hypnosis. One-day workshop at the Annual Meeting of the Virginia Psychological Association. Richmond, VA. Co-presenter: Richard B. Griffin, Psy.D.

October 15-17, 1998. How to interface applied psychophysiology, biofeedback, and psychotherapy in primary care medicine and complementary medicine settings. Three day continuing education workshop sponsored by the Association of Applied Psychophysiology and Biofeedback. Scottsdale, Arizona. Co-instructors: Ian E. Wickramasekera, Ph.D., Terence C. Davies, M.D., Steven Baskin, Ph.D.

June 8, 1998. "Effective application of the biopsychosocial model: A joint venture". Presentation in the Annual Family Medicine Review Course, Virginia Beach, Virginia. Co-presenter: S. Margaret Davies, M.D.

June 7, 1998. "Psychophysiology: Putting the mind-body relationship to work". Presentation in the Annual Family Medicine Review Course, Virginia Beach, Virginia.

June 6, 1998. "Efficient psychosocial screening: What you ask is what you get". Two-hour workshop at a National Symposium titled "Behavioral Medicine: Bridging the mind-body gap in patient care", Virginia Beach, VA. Co-presenters: Margaret Davies, MD, and Gregory Anderson, Ph.D.

October 17, 1997. "Introduction to clinical hypnosis". Two-hour workshop at the Annual Meeting of the Virginia Psychological Association. Hampton, VA. Co-presenter: Richard B. Griffin, Psy.D.

Aug. 9,1996. "Treating somatic symptoms effectively with hypnosis and psycho-physiological methods". American Psychological Association Continuing Education Program. One-day CE workshop for psychologists at the APA Annual Convention in Toronto. Co-instructors: Ian Wickramasekera, Ph.D., ABPP, ABPH; Richard B. Griffin, Psy.D.

Other presentations

September 29, 2009. Hypnotherapy. A one-hour lecture in the UNC-Chapel Hill course “Principles and Practice of Complementary and Alternative Medicine”. Chapel Hill, NC.

September 26, 2009.Natural History of Irritable Bowel Syndrome Episodes. Annual Research Day Symposium, Center for Functional GI and Motility Disorders. Chapel Hill, NC.

September 25, 2009. Nationwide Effectiveness Trial of Hypnosis for IBS. Annual Research Day Symposium, Center for Functional GI and Motility Disorders. Chapel Hill, NC.

September 25, 2009. Hypnosis for Functional Heartburn. Annual Research Day Symposium, Center for Functional GI and Motility Disorders. Chapel Hill, NC.

October 25, 2008. Hypnotherapy for Functional GI Disorders. Presentation in a Patient Symposium hosted by the UNC Center for Functional GI and Motility Disorders. Chapel Hill, NC.

October 4, 2008. CONQUEST Study: Impact of Constipation on Quality of Life and Healthcare Costs. Annual Research Day Symposium, Center for Functional GI and Motility Disorders. Chapel Hill, NC.

October 4, 2008. Characterization of IBS Symptom Episodes. Annual Research Day Symposium, Center for Functional GI and Motility Disorders. Chapel Hill, NC.

September 12, 2008. Hypnotherapy. A one-hour lecture in the UNC-Chapel Hill course “Principles and Practice of Complementary and Alternative Medicine”. Chapel Hill, NC.

September 28, 2007. Investigating the Role of Comorbidity in Irritable Bowel Syndrome. Presentation at the Annual Research Day Symposium, Center for Functional GI and Motility Disorders. Chapel Hill, NC.

September 7, 2007. Hypnotherapy. A one-hour lecture in the UNC-Chapel Hill course “Principles and Practice of Complementary and Alternative Medicine”. Chapel Hill, NC.

September 11, 2006. Hypnotherapy. A one-hour lecture in the UNC-Chapel Hill course "Principles and Practice of Complementary and Alternative Medicine". Chapel Hill, NC.

June 17, 2006. Comorbidity and somatization scales. Presentation at the Annual Research Day Symposium, Center for Functional GI and Motility Disorders. Chapel Hill, NC.

June 17, 2006. Development of bloating severity questionnaires. Presentation at the Annual Research Day Symposium, Center for Functional GI and Motility Disorders. Chapel Hill, NC.

June 15. 2006. Hypnosis for Functional GI disorders. Presentation in a Patient Symposium hosted by the UNC Center for Functional GI and Motility Disorders. Chapel Hill, NC.

June 15. 2006. Psychological treatments for functional GI disorders. Facilitation of a break-out session at the UNC Center for Functional GI and Motility Disorders. Chapel Hill, NC.

June 2005. Hypnosis treatment for IBS: The North Carolina model. Presentation at the Annual Research Day Symposium, Center for Functional GI and Motility Disorders. Chapel Hill, NC.

October 18, 2004. "Hypnosis treatment for Gastrointestinal Disorders". Family Medicine Grand Rounds, Department of Family Medicine, UNC-Chapel Hill, Chapel Hill, NC

July 16, 2004. "Hypnosis treatment for Gastrointestinal Disorders". Program for Integrative Medicine, Chapel Hill, NC

June 12, 2004. "Hypnosis treatment for Functional GI Disorders". Presentation in a Patient Symposium hosted by the UNC Center for Functional GI & Motility Disorders. Chapel Hill, NC

September 20, 2003. "Irritable Bowel Syndrome: What We Know About It and What Psychologists Can Do About It". Presentation at the 25th Anniversary Meeting of the Virginia Consortium Program in Clinical Psychology.

February 24, 2003. "Gender Differences in Irritable Bowel Syndrome". Preceptorship presentation for Novartis Pharmaceuticals Corp. Chapel Hill, NC.

February 25, 2003. "Psychological Treatment of Irritable Bowel Syndrome". Preceptorship presentation for Novartis Pharmaceuticals Corp. Chapel Hill, NC.

June 2002. "Gender Differences in Irritable Bowel Syndrome". Preceptorship presentation for Solvay Pharmaceuticals. Chapel Hill, NC.

June 2002. "Psychological treatment of Irritable Bowel Syndrome". Preceptorship presentation for Solvay Pharmaceuticals. Chapel Hill, NC.

January 17 2000. "Biofeedback". EVMS Radio Rounds. WHRO-FM Public Radio, Norfolk, Virginia.

January 18, 2000. "Clinical Hypnosis". EVMS Radio Rounds. WHRO-FM Public Radio, Norfolk, Virgina.

May 28, 1999. "The chronic pain patient in psychotherapy". A Seminar for doctoral students in clinical psychology, Virginia Consortium Program in Clinical Psychology, Virginia Beach, Virginia.

April 29, 1999. "Alternative medicine". Invited presentation at the 58th Annual Meeting of the National Association for Practical Nurse Education and Service. Virginia Beach, VA.

October 28, 1998. "Biofeedback: Mind over Matter". Grand Rounds presentation, EVMS Department of Internal Medicine.

June 6, 1998. "Mind-body medicine in the 21st Century: A sneak preview of new technologies and treatments". Presentation at a National Symposium titled "Behavioral Medicine: Bridging the mind-body gap in patient care", Virginia Beach, VA. Co-presenter: Alan T. Pope, Ph.D.

May 8, 1998. "Keeping stress from hurting your health". A presentation to the Suffolk Rotary Club. Suffolk, VA.

April 7, 1998. "Complementary medicine". One-hour radio presentation on public radio WHRO-FM in the Hear/Say program. Co-presenter: Alan Doyle, D.O.

February 21, 1998. "Psychophysiology: Putting the mind-body connection to work". Presentation at the American Medical Association's Conference of Mid-Atlantic States. Norfolk, Virginia.

November 11, 1997. "Overview of behavioral medicine programs for chronic headache, irritable bowel syndrome, and unsuccessful weight loss". Invited dinner presentation, Tidewater Academy of Clinical Psychologists. Norfolk, Virginia.

October 16, 1997. "How to keep stress from hurting your health". Tidewater Delta Gamma Women's Alumni Organization. Virginia Beach, Virginia.

October 4, 1997. "Biofeedback for pain management". Presentation at the Annual Meeting of the Virginia Association of Nurse Anesthesists. Virginia Beach, Virginia Beach.

September 4, 1997. "Biofeedback and the mind-body connection". One hour presentation for the Women's Wisdom Circle, a support group for women who have had breast cancer. Norfolk, Virginia.

August 20, 1997. "Your attitude and your health" . An invited presentation for the Kiwanis Club of Virginia Beach. Virginia Beach, Virginia.

June 17, 1997. "Neurofeedback treatment for attention-deficit/hyperactivity disorder: status and future prospects". Presentation in NASA/ODU/EVMS International Seminar on New Psychophysiological Treatments for Attention-Deficit/Hyperactivity Disorder. Old Dominion University. Norfolk Virginia.

May 20, 1997. "Behavioral medicine techniques in the management of pain". Invited presentation for residents in the EVMS Department of Physical Medicine and Rehabilitation".

March 20 and 27, 1997. "Introduction to clinical hypnosis". A two-part six-hour workshop for the residents in psychiatry. Eastern Virginia Medical School. Co-instructor: Richard B. Griffin, Psy.D.

February 20, 1997. "Keeping stress from affecting your health". Presentation open to the public, Eastern Virginia Medical School.

February 14, 1997. "Behavioral medicine". One-hour radio presentation on public radio WHRV-FM in the Hear/Say program. Co-presenters: Barbara A. Cubic, Ph.D., and Richard B. Griffin, Psy.D. Norfolk, Virginia.

February 8, 1997 "Introduction to hypnosis in clinical practice". Two-hour workshop at the EVMS Medical Students Annual Retreat. Nags Head, SC. Co-presenter: Angela Stroup, RN, MA.

Sept. 25 1996. "Results of the functional GI disorders questionnaire study". Gastroenterology pathophysiology conference, UNC-Chapel Hill Department of Medicine. Co-presenter: William E. Whitehead, Ph.D.

Apr. 18, 1996. "Gastrointestinal neuropeptides in irritable bowel syndrome patients and healthy subjects". Paper presented in the 1996 Research Competition of the Center for Gastrointestinal Biology and Disease. University of North Carolina at Chapel Hill.

Jan. 29, 1996. "Munchhausen's syndrome? Review and case discussion". Presentation in a seminar series for GI division medical and research staff. UNC Functional Gastrointestinal Disorders Center, Memorial Hospital, Chapel Hill. Co-presenters: William Harlan III, MD, and Charles K. Burnett, Ph.D., Dr.PH.

Oct. 25, 1995. "Pain perception and psychological adjustment in irritable bowel syndrome: The relationship to abuse history". Presentation in a seminar series for GI division medical and research staff. UNC Functional Gastrointestinal Disorders Center, Memorial Hospital, Chapel Hill. Co-presenter: William E. Whitehead, Ph.D.

Sept. 27, 1995. "Autogenic training and hypnosis". Presentation in a seminar series for GI division medical and research staff. UNC Functional Gastrointestinal Disorders Center, Memorial Hospital, Chapel Hill.

Aug.30, 1995. "Psychological Approaches II: Psychological testing. Utility in the medical setting, appropriate referral questions, etc. Presentation in seminar series for GI division medical and research staff. UNC Functional Gastrointestinal Disorders Center, Memorial Hospital, Chapel Hill. Co-presenter: Charles K. Burnett, Ph.D., Dr.P.H.

April 12, 1995. "Hypnosis treatment for irritable bowel syndrome: How does it work?" Gastroenterology pathophysiology conference, UNC-Chapel Hill Department of Medicine.

March 15, 1995. "Somatization II". Presentation in seminar series for GI division medical and research staff. UNC Functional Gastrointestinal Disorders Center, Memorial Hospital, Chapel Hill.

Nov. 9, 16 & 23, 1994. "Pain management I, II and III". Presentations in seminar series for GI division medical and research staff. UNC Functional Gastrointestinal Disorders Center, Memorial Hospital, Chapel Hill.

Sept. 28, 1994. "Hypnosis and irritable bowel syndrome". Presentation in seminar series for GI division medical and research staff. UNC Functional Gastrointestinal Disorders Center, Memorial Hospital, Chapel Hill.

April 14, 1994. "Stress reduction treatment by means of group hypnosis". Invited lecture, Psychiatric Grand Rounds, Eastern Virginia Medical School, Norfolk, Virginia.

Nov. 29, 1993. "Stress". Invited presentation, Department of Health Education, University of Maryland at College Park. College Park, Maryland.

Nov. 6 & 10, 1992. "Hypnosis and hypnotherapy". Two-part presentation and clinical demonstration for the psychotherapy staff at the North Central Human Service Center. Minot, North Dakota.

July 25, 1992. "Stress reduction via group hypnosis". Invited presentation at the annual meeting of the Virginia Hypnosis Society. Norfolk, Virginia.



Return to IBShypnosis.com Index Page